Supernus Pharmaceuticals, Inc. lèt majiskil
Supernus Pharmaceuticals, Inc. kapitalize mache an dola jodi a. Chak jou, nou anrejistre yon chanjman nan majiskil Supernus Pharmaceuticals, Inc.. Baze sou komès nan stock stock Supernus Pharmaceuticals, Inc. sou mache dechanj, ou ka evalye lèt majiskil nan Supernus Pharmaceuticals, Inc.. Supernus Pharmaceuticals, Inc. mache kap jodi a egal a 1 961 582 976 dola ameriken.
Supernus Pharmaceuticals, Inc. volim nan komès
Supernus Pharmaceuticals, Inc. komès komès jodi a totalize $ 70 224. Tablo chak jou nan Supernus Pharmaceuticals, Inc. komès volim prezante sou sit entènèt nou an. Supernus Pharmaceuticals, Inc. komès sou entènèt ki te fèt sou pifò echanj machandiz sou entènèt, sit entènèt nou an montre total komès volim Supernus Pharmaceuticals, Inc. pou chak jou. Valè tout aksyon Supernus Pharmaceuticals, Inc. ki emèt (Supernus Pharmaceuticals, Inc. kap mache) tonbe nan $ -62 325 248.
|
Supernus Pharmaceuticals, Inc. mache bouchon tablo
Supernus Pharmaceuticals, Inc. majiskil sou yon graf pa ane. -1.84% - yon chanjman nan lèt majiskil sou mache Supernus Pharmaceuticals, Inc. pou chak semèn. 0% chak mwa - yon chanjman nan lèt majiskil sou mache Supernus Pharmaceuticals, Inc.. Supernus Pharmaceuticals, Inc. kap mache pi gran yè.
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Supernus Pharmaceuticals, Inc. Istwa kapitalizasyon
| Dat |
Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
|
|---|---|
| 04/05/2023 | 1 961 582 976 $ |
| 03/05/2023 | 2 023 908 224 $ |
| 02/05/2023 | 2 015 751 680 $ |
| 01/05/2023 | 2 008 003 072 $ |
| 28/04/2023 | 2 004 332 544 $ |
| 27/04/2023 | 1 996 719 872 $ |
| 26/04/2023 | 1 998 351 104 $ |
Supernus Pharmaceuticals, Inc. tablo volim
| Semèn | Mwa | 3 mwa | Ane | 3 zan |
Supernus Pharmaceuticals, Inc. done istwa volim
| Dat |
Volim (24h)
Volim komèsyal de aksyon Supernus Pharmaceuticals, Inc. se kantite total tout tranzaksyon ak aksyon SUPN achte ak vann pandan dat la chwazi a.
|
|---|---|
| 04/05/2023 | 70 224 $ |
| 03/05/2023 | 279 964 $ |
| 02/05/2023 | 110 279 $ |
| 01/05/2023 | 4 619 $ |
| 28/04/2023 | 162 750 $ |
| 27/04/2023 | 40 220 $ |
| 26/04/2023 | 181 559 $ |
Sou 04/05/2023, Supernus Pharmaceuticals, Inc. lèt majiskil mache a te $ 1 961 582 976. 03/05/2023 Supernus Pharmaceuticals, Inc. lèt majiskil mache egal a 2 023 908 224 dola ameriken. Supernus Pharmaceuticals, Inc. majiskil nan 02/05/2023 montan pou 2 015 751 680 dola ameriken. Lèt majiskil sou mache Supernus Pharmaceuticals, Inc. montan pou 2 008 003 072 dola ameriken nan 01/05/2023.
28/04/2023 Supernus Pharmaceuticals, Inc. majiskil montan pou 2 004 332 544 dola ameriken. Lèt majiskil sou mache Supernus Pharmaceuticals, Inc. nan 27/04/2023 montan pou 1 996 719 872 dola ameriken. 26/04/2023 Supernus Pharmaceuticals, Inc. majiskil montan pou 1 998 351 104 dola ameriken.
Lèt majiskil Supernus Pharmaceuticals, Inc. jodi a se 1 961 582 976 $. Kapitalizasyon sou mache a nan Supernus Pharmaceuticals, Inc. te chanje a -3.0795% konpare ak yè. Volim komèsyal de aksyon SUPN nan Supernus Pharmaceuticals, Inc. nan dènye jou komès montan pou 70 224 $. Volim komèsyal de aksyon de Supernus Pharmaceuticals, Inc. chanje pou -74.917% konpare ak jou komès anvan an.